T1	disease_or_phenotypic_feature 1 17	Multiple myeloma
T2	chemical 49 56	biology
T3	chemical 100 111	tesofensine
T4	chemical 138 147	inhibitor
T5	disease_or_phenotypic_feature 172 179	obesity
T6	chemical 185 196	semaglutide
T7	disease_or_phenotypic_feature 269 276	obesity
T8	chemical 278 288	Fluoxetine
T9	disease_or_phenotypic_feature 306 313	seizure
T10	chemical 452 456	drug
T11	chemical 457 468	bezafibrate
T12	chemical 565 569	drug
T13	chemical 570 581	bezafibrate
T14	disease_or_phenotypic_feature 661 667	cancer
T15	disease_or_phenotypic_feature 668 676	cachexia
T16	chemical 694 698	drug
T17	disease_or_phenotypic_feature 708 721	renal failure
T18	chemical 733 742	clonidine
T19	chemical 752 761	lidocaine
T20	chemical 791 801	anesthesia
T21	disease_or_phenotypic_feature 805 813	cataract
T22	chemical 823 834	Cannabidiol
T23	chemical 839 843	drug
T24	disease_or_phenotypic_feature 854 862	seizures
T25	disease_or_phenotypic_feature 870 885	Dravet syndrome
T26	chemical 908 914	oxygen
T27	disease_or_phenotypic_feature 962 985	squamous cell carcinoma
T28	chemical 1125 1131	oxygen
T29	chemical 1157 1163	oxygen
T30	chemical 1215 1226	amphetamine
T31	disease_or_phenotypic_feature 1238 1245	obesity
T32	chemical 1252 1255	RAS
T33	disease_or_phenotypic_feature 1280 1286	cancer
T34	chemical 1287 1294	biology
T35	chemical 1422 1430	antigens
T36	disease_or_phenotypic_feature 1464 1477	neuroblastoma
T37	chemical 1490 1494	drug
T38	disease_or_phenotypic_feature 1554 1571	lymph node tumors
T39	disease_or_phenotypic_feature 1645 1658	tongue cancer
T40	chemical 1668 1674	oxygen
T41	disease_or_phenotypic_feature 1709 1722	hyperglycemic
T42	disease_or_phenotypic_feature 1734 1738	coma
T43	chemical 1773 1783	anesthesia
T44	disease_or_phenotypic_feature 1889 1906	colorectal cancer
T45	chemical 1938 1945	antigen
T46	chemical 2007 2011	drug
T47	disease_or_phenotypic_feature 2020 2026	ataxia
T48	disease_or_phenotypic_feature 2039 2045	ataxia
T49	disease_or_phenotypic_feature 2047 2053	ataxia
T50	disease_or_phenotypic_feature 2128 2136	dystonic
T51	chemical 2252 2256	drug
T52	disease_or_phenotypic_feature 2273 2276	CTX
T53	chemical 2286 2289	DDP
T54	chemical 2351 2360	rapamycin
T55	chemical 2361 2371	inhibitors
T56	chemical 2400 2411	aldosterone
T57	disease_or_phenotypic_feature 2425 2436	hypokalemia
T58	disease_or_phenotypic_feature 2441 2457	hypophosphatemia
T59	chemical 2464 2474	inhibitors
T60	disease_or_phenotypic_feature 2507 2520	heart failure
T61	disease_or_phenotypic_feature 2542 2552	arrhythmia
T62	chemical 2630 2634	drug
T63	disease_or_phenotypic_feature 2643 2659	hypersensitivity
T64	disease_or_phenotypic_feature 2661 2669	diarrhea
T65	disease_or_phenotypic_feature 2671 2678	seizure
T66	disease_or_phenotypic_feature 2680 2690	arrhythmia
T67	disease_or_phenotypic_feature 2703 2716	renal failure
T68	disease_or_phenotypic_feature 2746 2755	pneumonia
T69	chemical 2772 2777	toxin
T70	disease_or_phenotypic_feature 2786 2807	peripheral neuropathy
T71	corrected_chemical 122 147	triple reuptake inhibitor
R1	treats Arg1:T3 Arg2:T5	
R2	treats Arg1:T71 Arg2:T5	
T72	missed_chemical 201 218	oral GLP-1 analog
T73	missed_disease_or_phenotypic_feature 232 240	diabetes
R3	treats Arg1:T6 Arg2:T73	
R4	treats Arg1:T72 Arg2:T73	
R5	treats Arg1:T6 Arg2:T7	
R6	treats Arg1:T72 Arg2:T7	
R7	causes_or_contributes_to Arg1:T8 Arg2:T9	
T74	corrected_chemical 433 456	antihyperlipidemic drug
T75	missed_disease_or_phenotypic_feature 346 368	decreased LPL activity
R15	treats Arg1:T22 Arg2:T24	
R16	treats Arg1:T22 Arg2:T25	
R17	treats Arg1:T30 Arg2:T31	
T79	corrected_chemical 1479 1494	Anticancer drug
T80	missed_disease_or_phenotypic_feature 1527 1541	primary tumors
T81	corrected_disease_or_phenotypic_feature 1543 1571	metastatic lymph node tumors
T82	missed_disease_or_phenotypic_feature 1573 1589	recurrent tumors
R18	treats Arg1:T79 Arg2:T80	
R19	treats Arg1:T79 Arg2:T81	
R20	treats Arg1:T79 Arg2:T82	
R21	treats Arg1:T79 Arg2:T39	
R22	causes_or_contributes_to Arg1:T46 Arg2:T47	
T83	corrected_chemical 2331 2371	Mammalian target of rapamycin inhibitors
T84	missed_disease_or_phenotypic_feature 2379 2391	hyponatremia
R23	causes_or_contributes_to Arg1:T83 Arg2:T84	
R24	causes_or_contributes_to Arg1:T83 Arg2:T57	
R25	causes_or_contributes_to Arg1:T83 Arg2:T58	
T86	missed_disease_or_phenotypic_feature 2522 2537	thromboembolism
T87	corrected_chemical 2459 2474	VEGF inhibitors
T88	missed_disease_or_phenotypic_feature 2493 2505	hypertension
R27	causes_or_contributes_to Arg1:T87 Arg2:T88	
R28	causes_or_contributes_to Arg1:T87 Arg2:T60	
R29	causes_or_contributes_to Arg1:T87 Arg2:T86	
R30	causes_or_contributes_to Arg1:T87 Arg2:T61	
R31	causes_or_contributes_to Arg1:T62 Arg2:T63	
R32	causes_or_contributes_to Arg1:T62 Arg2:T64	
R33	causes_or_contributes_to Arg1:T62 Arg2:T65	
R34	causes_or_contributes_to Arg1:T62 Arg2:T66	
T89	corrected_disease_or_phenotypic_feature 2692 2699;2709 2716	hepatic failure
R35	causes_or_contributes_to Arg1:T62 Arg2:T89	
R36	causes_or_contributes_to Arg1:T62 Arg2:T67	
R37	causes_or_contributes_to Arg1:T69 Arg2:T70	
T76	corrected_disease_or_phenotypic_feature 661 676	cancer cachexia
R10	treats Arg1:T13 Arg2:T76	
T77	corrected_chemical 546 569	antihyperlipidemic drug
R11	treats Arg1:T77 Arg2:T76	
R8	treats Arg1:T16 Arg2:T17	
R9	treats Arg1:T23 Arg2:T24	
R12	treats Arg1:T23 Arg2:T25	
T78	missed_chemical 2757 2767	Medication
R13	causes_or_contributes_to Arg1:T78 Arg2:T70	
R14	causes_or_contributes_to Arg1:T74 Arg2:T75	
R26	causes_or_contributes_to Arg1:T11 Arg2:T75	
T85	missed_disease_or_phenotypic_feature 1982 1991	imbalance
R38	causes_or_contributes_to Arg1:T46 Arg2:T85	
